Zydus gets USFDA nod for drugs treating fungal infections, skin disorder
Company will manufacture Fluconazole tablets at its Baddi facility17-02-2017
17-02-2017
Fixes Record Date for Interim Dividend
Zydus Wellness Ltd has informed BSE that the Company has fixed March 10, 2017 as the Record Date for the purpose of Payment of Interim Dividend, if declared.17-02-2017
Board to consider Interim Dividend
Zydus Wellness Ltd has informed BSE that the Meeting of Board of Directors of the Company will be held on March 01, 2017, to consider, the proposal for declaration of Interim Dividend, if any, for the financial year 2016-2017.Further, as per code of conduct for prevention of Insider Trading adopted by the Company under SEBI [Prohibition of Insider Trading] Regulations, 2015, the Trading Window will remain closed from February 20, 2017 to...17-02-2017
Zydus Wellness Q3 profits fall
Cadila Healthcare's subisidiary Zydus Wellness saw flat income for Q3 compared to last year's quarter, and saw profits decline 8.2% to Rs. 25.14 crore. Besides SugarFree, the company also has the brands EverYuth and Nutralite in its stable.30-01-2017
Results Press Release for December 31, 2016
Zydus Wellness Ltd has informed BSE about : 1. Result Press Release for the period ended December 31, 201630-01-2017
Standalone & Consolidated Financial Results, Limited Review Report for December 31, 2016
Zydus Wellness Ltd has informed BSE about : 1. Standalone Financial Results for the period ended December 31, 20162. Consolidated Financial Results for the period ended December 31, 20163. Standalone Limited Review for the period ended December 31, 20164. Consolidated Limited Review for the period ended December 31, 201630-01-2017
Change in time of Analyst / Institutional Investors' meet
Zydus Wellness Ltd has informed BSE regarding "Change in the time of Analyst / Institutional Investors' meet".27-01-2017
Zydus adds muscle with US buy
String of brand buying in India to give it more diversified portfolio21-01-2017
Schedule of Analyst / Institutional Investors' meet
Zydus Wellness Ltd has informed BSE regarding "Schedule of Analyst / Institutional Investors' meet".19-01-2017
Zydus gets USFDA nod for chemotherapy drug
The drug will be produced at the group's manufacturing facility in Ahmedabad18-01-2017